HolonIQ released its 2022 Asia Health Tech 200 list of the most promising innovative companies, which is divided into nine categories: Prevention, Research, Care, Supply Chain, Hardware, Finance, Treatment, Systems, and Diagnosis.
META Pharmaceuticals was selected in the Research category for its groundbreaking research in the field of immuno-metabolism.
